SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas rocket-thruster Roadster demonstration drove intense discussion, but traders largely framed the sharp reversal after an initial pop as a sell the news reaction, questioning the cars practicality and near-term earnings impact. Some see the demo as an impressive technology showcase and speculate it could strengthen a TeslaSpaceX merger case, though no merger has been announced; broader weakness in tech stocks also weighed on shares.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is caught in a broader semiconductor selloff as investors question the sustainability and financing of AI spending; traders also cite CEO Hock Tans comments about capital constraints and speculative AI investing as adding to the pressure. The community is split between bearish concerns about AI demand and the remarks impact, and bulls who see the decline as a sector-wide pullback and continue to buy on weakness.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp, high-volume selloff with no reported company-specific news has focused discussion on suspected options-expiration pressure near the $10 strike and weakness across biotech stocks. Traders remain focused on the delayed 80th-event update and eventual Phase 3 REGAL data, with bullish dip-buyers viewing the decline as technical while skeptics cite the prolonged quiet period and uncertainty around the trial.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCIs steep selloff amid a broader AI-infrastructure pullback is driving attention, with traders debating whether sector weakness and lingering governance and export-control concerns outweigh the appointment of new CFO Mark Long. Some view the decline as an overdone buying opportunity, while others expect further weakness and question managements credibility.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digitals steep decline is being discussed amid a broader storage and AI-hardware selloff, with traders citing Toshibas planned HDD capacity expansion and Wells Fargos price-target cut as sources of pressure. Some see the concerns as overblown given AI-driven storage demand and upcoming earnings, while others point to continued selling and weak technical momentum.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is drawing attention amid a semiconductor and technology selloff, with traders linking its decline to weakness in chip stocks and concerns about the AI trade. Some investors are buying the dip for the ETFs weekly distributions, while others question payout sustainability and warn that falling semiconductor prices can pressure its share value.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXYs sharp gain has sparked bets on a broader volatility spike, with traders pointing to market weakness and concerns about rates, oil, and geopolitical risks. Views are divided: some expect volatility to climb further, while others see a short-lived pop and cite the ETFs futures exposure and decay as reasons to fade rallies.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

OUST is drawing attention after a sharp pullback alongside weakness in AI and growth stocks, with traders debating whether the decline is an overreaction or a sign of further downside. Many are buying or averaging down, while others point to the stocks volatile trading and weakening chart.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

A sharp pullback in biotech stocks, reflected in weakness across the XBI, is driving attention to LABU, whose 3 leverage magnifies sector moves. Traders debate whether the declineoften linked in the discussion to inflation and higher-rate concernsis a buying opportunity or the start of further losses, with some favoring LABD or short trades.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABDs gain is drawing attention as traders position for further biotech weakness, citing XBIs decline and concerns that hot inflation data and higher rates could pressure the sector. The bearish view is contested by traders expecting a biotech rebound, with many emphasizing the sharp swings and decay risk of the leveraged inverse ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases PR Newswire HAMBURG, Germany, Aug. 6, 2026 Collaboration combines Odyssey's disease...

Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower

Equity

The Boston-based clinical-stage biopharmaceutical company raised $279 million through an upsized offering, issuing 15.5 million shares of its common stock.

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.

Odyssey Therapeutics Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$17.17
Prev Close	$17.57
Open	$17.45
Dividend Yield	N/A
50-Day Moving Average	$22.40
Beta	0.61
Avg. Volume	392,406.70
PE Ratio	N/A

52-Week High	$29.05
52-Week Low	$15.10
Market Capitalization	$844.39M
EPS (Annual)	-$3.15
Price to Book	2.00
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

ODTX Fundamentals